Tan Yann Chong
Algemeen Directeur bij Nuevocor Pte Ltd.
Actieve functies van Tan Yann Chong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Algemeen Directeur | - | - |
Oprichter | - | - |
Loopbaan van Tan Yann Chong
Eerdere bekende functies van Tan Yann Chong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Esco Ventures Pte Ltd.
Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Private Equity Investor | - | 01-08-2022 |
Opleiding van Tan Yann Chong
Stanford University | Graduate Degree |
Duke University | Undergraduate Degree |
Statistieken
Internationaal
Singapore | 3 |
Verenigde Staten | 3 |
Operationeel
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Esco Ventures Pte Ltd.
Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Finance |
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Tan Yann Chong
- Ervaring